InvestorsHub Logo

DewDiligence

08/13/15 9:40 AM

#9 RE: DewDiligence #4

GLMD had $27.8M of cash at 6/30/15—a burn of $2.1M during 2Q15:

http://finance.yahoo.com/news/galmed-pharmaceuticals-announces-commencement-patient-114500880.html

GLMD claims the cash balance is enough to last “into 2017,” but that seems like a stretch. The company has a $150M shelf registration (#msg-112291490).